LPCN - Lipocine Inc - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

-12.9M

Cash

25.79M

Avg Qtr Burn

-3.069M

Short % of Float

2.67%

Insider Ownership

2.82%

Institutional Own.

11.10%

Qtr Updated

06/30/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
LPCN 1144 Details Non-alcoholic steatohepatitis	Phase 3 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
LPCN 1107 Details Preterm birth	Phase 3 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Brexanolone (LPCN 1154) Details Postpartum depression	Phase 3 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
LPCN 1148 Details Cirrhosis	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.